Bump Stock Ban, the Abortion Pill and Social Media Regulation on the Docket
Garland v. Cargill, FDA v. Alliance for Hippocratic Medicine, Moody v. NetChoice and Others
Below is the status of key cases granted certiorari by the U.S. Supreme Court for consideration during the October 2023 (Oct. 2, 2023, to Oct. 6, 2024) term, as of Jan. 28, 2024. Cases are organized by certiorari date within each section. Abortion Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine — This case was granted certiorari on Dec. 13, 2023, and has yet to be scheduled for argument. At issue is whether the FDA approval of and subsequent rulemaking for the abortion drug mifepristone was “arbitrary and capricious” in violation of federal law. Moyle v. United States…
